Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Comparative Cardiac Safety of Covalent and Non-Covalent Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma- A Multi-Center Retrospective Cohort Study

MCL - 524

Comparative Cardiac Safety of Covalent and Non-Covalent Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma- A Multi-Center Retrospective Cohort Study

Aditya Anand

Poster Presenter: Aditya Anand

Thumbnail for Comparative Cardiovascular and Infectious Safety of Acalabrutinib Versus Zanubrutinib in Chronic Lymphocytic Leukemia: A Propensity Score-Matched Real-World Analysis of the TriNetX Global Collaborative Network

CLL - 1316

Comparative Cardiovascular and Infectious Safety of Acalabrutinib Versus Zanubrutinib in Chronic Lymphocytic Leukemia: A Propensity Score-Matched Real-World Analysis of the TriNetX Global Collaborative Network

Muhammad Usman Haider

Poster Presenter: Muhammad Usman Haider

Previous 1...23 24 25 26 27 28 29...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Comparative Cardiovascular Safety of Ibrutinib, Acalabrutinib, and Zanubrutinib: A FAERS Disproportionality Analysis

CLL - 337

Comparative Cardiovascular Safety of Ibrutinib, Acalabrutinib, and Zanubrutinib: A FAERS Disproportionality Analysis

Alexander den Boef

Poster Presenter: Alexander den Boef

Thumbnail for Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin in Acute Myeloid Leukemia-Associated Venous Thromboembolism: A Propensity-Matched Real-World Analysis

AML - 655

Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin in Acute Myeloid Leukemia-Associated Venous Thromboembolism: A Propensity-Matched Real-World Analysis

Ani Toloraia

Poster Presenter: Ani Toloraia

Thumbnail for Comparative Effectiveness and Safety of Talquetamab Versus Teclistamab in Multiple Myeloma: A Real-World Propensity-Matched Study

MM - 1377

Comparative Effectiveness and Safety of Talquetamab Versus Teclistamab in Multiple Myeloma: A Real-World Propensity-Matched Study

Rukash Khan Niazi

Poster Presenter: Rukash Khan Niazi

$Thumbnail for Comparative Effectiveness of Epcoritamab, Lenalidomide, and Rituximab (E+R2) in EPCORE FL-1 vs Real-World Chemoimmunotherapy (CIT) in Relapsed/Refractory Follicular Lymphoma (R/R FL)$

IBCL - 1346

Comparative Effectiveness of Epcoritamab, Lenalidomide, and Rituximab (E+R2) in EPCORE FL-1 vs Real-World Chemoimmunotherapy (CIT) in Relapsed/Refractory Follicular Lymphoma (R/R FL)

Habte Yimer

Poster Presenter: Habte Yimer

Thumbnail for Comparative Effectiveness of Standard 3+7 Versus FLAG/FLAG-IDA Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia: A Propensity Score-Matched Cohort Study Using the TriNetX Global Network

AML - 138

Comparative Effectiveness of Standard 3+7 Versus FLAG/FLAG-IDA Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia: A Propensity Score-Matched Cohort Study Using the TriNetX Global Network

Rita Ahmad

Poster Presenter: Rita Ahmad

Thumbnail for Comparative Effectiveness of Surveillance by Molecular, Genetic, and Imaging Modalities in Indolent Follicular Non-Hodgkin Lymphomas

IBCL - 038

Comparative Effectiveness of Surveillance by Molecular, Genetic, and Imaging Modalities in Indolent Follicular Non-Hodgkin Lymphomas

Niravkumar Brahmbhatt

Poster Presenter: Niravkumar Brahmbhatt

$Thumbnail for Comparative Efficacy and Safety of Approved Therapies in =3L Relapsed/Refractory Large B-Cell Lymphoma: A Bayesian Network Meta-Analysis$

ABCL - 1491

Comparative Efficacy and Safety of Approved Therapies in =3L Relapsed/Refractory Large B-Cell Lymphoma: A Bayesian Network Meta-Analysis

Nain Tara

Poster Presenter: Nain Tara

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors